Hope Jason 13D/13G Filings for Outlook Therapeutics, Inc. (OTLK)

Hope Jason 13D and 13G filings for Outlook Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-17
8:14 pm
Purchase
2022-12-3113GOutlook Therapeutics, Inc.
OTLK
Hope Jason1,000,000
7.800%
249,382increase
(+33.22%)
Filing
2022-04-01
4:31 pm
Purchase
2022-03-1813GOutlook Therapeutics, Inc.
OTLK
Hope Jason750,618
6.690%
750,618increase
(New Position)
Filing